A study of the safety of CMA-676 [gemtuzumab ozogamicin] in treatment of elderly patients with acute myeloid leukemia (AML) in first relapse
Phase of Trial: Phase II
Latest Information Update: 25 Sep 2005
At a glance
- Drugs Gemtuzumab ozogamicin (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 25 Sep 2005 New trial record.